Thrombophilia Life Insurance in 2026: IUL and GUL Options Explained
Bottom Line
IUL or GUL coverage may be possible with thrombophilia, including past blood clots when treatment is stable. Your exact clotting disorder, recurrence history and any bleeding complications from anticoagulants matter more than the diagnosis label alone.
Thrombophilia does not rule out indexed universal life (IUL) or guaranteed universal life (GUL) coverage, though most applicants should expect a table rating. This guide explains why clotting disorders such as Factor V Leiden affect rates, what underwriters evaluate, how IUL and the fixed premium GUL option compare, and how table ratings work in real dollars. For readers who want that fixed GUL premium held into their nineties, our guide to guaranteed universal life rates pairs the no-lapse guarantee with the rate bands each insurer publishes.
Yes, You Can Get Life Insurance with Thrombophilia
If you have been diagnosed with a clotting disorder, you may have heard that life insurance is difficult or even impossible to get. That is simply not true. Many of our clients with thrombophilia, whether it is Factor V Leiden, Prothrombin gene mutation, Protein C or S deficiency, or antiphospholipid syndrome, have successfully secured permanent life insurance. The key is understanding what underwriters look for and working with an agency that knows which carriers view your specific condition most favorably.
For people with thrombophilia who want lifelong protection, two types of universal life insurance stand out as strong fits.
Why Thrombophilia Affects Your Rates
From an underwriter’s perspective, thrombophilia increases the statistical risk of blood clots, deep vein thrombosis, pulmonary embolism, and stroke. These are serious medical events that can be life threatening. Insurance carriers price that added risk into your premium through a system called table ratings.
However, not all clotting disorders carry the same weight. A person with heterozygous Factor V Leiden who has never had a clotting event looks very different to an underwriter than someone with antiphospholipid syndrome and a history of multiple DVTs. Your specific diagnosis, clotting history, and current treatment plan all play a role in determining where you land on that rating scale.
Thrombophilia and IUL: Indexed Universal Life Options
An indexed universal life policy ties your cash value growth to a market index like the S&P 500, with a floor that protects you from losses. For someone with thrombophilia, an IUL can be appealing because of its flexibility. If your health improves or your condition remains stable for several years, some carriers allow you to request a re-evaluation of your rating class.
When we help clients with clotting disorders apply for IUL coverage, we focus on carriers that are more lenient with blood disorders. The cash value component of an IUL also means your policy builds an asset over time, which can partially offset the higher premiums that come with a table rating.
Thrombophilia and GUL: Guaranteed Universal Life Coverage
A guaranteed universal life policy works differently. It locks in a fixed premium and a guaranteed death benefit for a specific period (often to age 90, 95, 100, or even 121) without the cash value growth component. Think of GUL as the most affordable way to get permanent, lifelong coverage.
For many thrombophilia clients, GUL is the practical choice. Because GUL premiums are already lower than whole life or IUL for the same death benefit amount, the impact of a table rating feels less painful on your monthly budget. A 40 year old looking at $500,000 in GUL coverage might pay around $180 per month at standard rates. With a Table 2 rating, that could move to roughly $270 per month. With a Table 4 rating, expect closer to $360 per month. Those are real numbers, but they are also very manageable when you consider the permanent protection your family receives.
What Underwriters Evaluate for Clotting Disorders
Every carrier’s underwriting team looks at a specific set of factors when reviewing a thrombophilia case. Here is what moves the needle.
- Your specific diagnosis and whether it is inherited or acquired
- History of clotting events (DVT, PE, stroke, or none)
- Current anticoagulant therapy and compliance
- How long you have been stable on treatment
- Any complications from blood thinners (bleeding events)
- Additional risk factors like smoking, obesity, or oral contraceptive use
- Lab results showing INR levels or anti-Xa levels if on blood thinners
- Family history of clotting events
A person with a single inherited mutation, no clotting events, and stable anticoagulant management will likely land in the Table 2 to Table 4 range. Someone with acquired antiphospholipid syndrome and recurrent clotting events faces Table 6 to Table 8 or higher.
How Table Ratings Work in Real Dollars
Table ratings add a percentage above standard rates. Table 1 adds 25%, Table 2 adds 50%, Table 4 adds 100% (double the standard rate), and so on up to Table 10 at 250%. The difference between landing at Table 2 versus Table 4 on a permanent policy can mean tens of thousands of dollars over your lifetime. This is exactly why carrier selection matters so much for thrombophilia cases.
Why an Independent Agency Makes a Bigger Difference for Rated Cases
Here is the truth that most people with thrombophilia never hear. Different carriers can rate the exact same clotting disorder two to four tables apart. One carrier might see your well managed Factor V Leiden as a Table 4 case, while another views it as Table 2. Over 30 or 40 years of permanent coverage, that gap could save you $30,000 or more.
Insurance By Heroes was founded by a former first responder and military spouse, and every member of our team comes from a background in public service. That service first mentality means we do the legwork of comparing many carriers on your behalf. We treat every client’s case with the same level of care we brought to protecting our communities. Whether you are a fellow first responder or a parent working from home, our job is finding you the best possible outcome.
Because we are independent, we are not locked into one carrier’s underwriting guidelines. We know which companies are more favorable toward blood disorders, which ones weigh clotting history differently, and which ones offer the best IUL or GUL products for rated cases.
Positioning Yourself for the Best Rating
Before you apply, gather your documentation and make sure your medical story is presented clearly. The following steps can help.
- Get a current hematology report showing your diagnosis, treatment plan, and stability
- Have recent lab work available (INR, anti-Xa levels, CBC)
- Document your medication compliance and any dose adjustments
- If you have been clot free for several years, make sure that is clearly noted in your records
- Address any additional risk factors you can control, such as weight, smoking, or activity level
Timing also matters. If you were recently diagnosed or just started anticoagulant therapy, waiting six to twelve months to show stability on treatment can significantly improve your rating. However, do not wait too long. Every year you age, your base premium increases, and the risk of a new clotting event could make future applications more complicated.
Common Mistakes That Cost You Money
When we work with thrombophilia clients, we often see the same avoidable errors.
- Applying to a single carrier without shopping the market. This almost always results in overpaying.
- Not specifying the exact type of clotting disorder. “Blood clotting condition” is too vague for underwriters.
- Failing to mention that you have been clot free for years. Stability is one of the strongest factors in your favor.
- Not disclosing anticoagulant use upfront. Underwriters will find it in your medical records, and surprises always hurt your case.
- Assuming you cannot afford coverage and going without it. A rated policy still protects your family. The cost of a Table 4 GUL policy is often less than a daily coffee habit.
FAQ
How much more does life insurance cost with thrombophilia?
Most thrombophilia cases receive a Table 2 to Table 6 rating, meaning premiums range from 50% to 150% above standard rates. On a $500,000 GUL policy for a 40 year old, that could mean paying $270 to $450 per month instead of the standard $180. Shopping through an independent agency can often bring you closer to the lower end of that range.
Can I get approved for IUL or GUL with a history of blood clots?
Yes. Even with a history of DVT or pulmonary embolism, approval is possible if the events are in the past and you are stable on treatment. Carriers want to see at least one to two years of stability with no new clotting events. The further you are from your last event, the better your options become.
Should I choose IUL or GUL if I have thrombophilia?
It depends on your goals. GUL is typically the most affordable path to permanent coverage, which matters when you are already paying a table rated premium. IUL offers cash value growth potential and flexibility, but the higher premiums amplified by a table rating may stretch your budget. Many of our thrombophilia clients choose GUL for the core death benefit and add other savings strategies separately.
Does the type of thrombophilia affect my life insurance options?
Absolutely. Inherited conditions like heterozygous Factor V Leiden with no clotting history are viewed far more favorably than acquired conditions like antiphospholipid syndrome. The number of genetic mutations (heterozygous versus homozygous) also matters significantly. Your specific diagnosis is the single most important factor in determining your rating class, which is why working with an agency experienced in blood disorder cases is so valuable.
Related health conditions
The same table-rated IUL and GUL route applies to other diagnoses underwriters review closely, including Hepatic Steatosis IUL and GUL life insurance, IUL and GUL life insurance with carotid stenosis, IUL and GUL life insurance with behcet's disease, Asbestosis IUL and GUL life insurance and Lung Nodule IUL and GUL life insurance.